Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which nerve monitor tells the truth in toddlers?

NCT ID NCT06409260

Diagnosis Sponsor: Matias Vested Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time

Summary

Researchers compare two devices that monitor how well muscles recover from a paralyzing drug during surgery in children aged 6 months to 2 years. The devices, electromyography and acceleromyography, are placed on nerves in the arm or leg. The trial measures how long it takes for muscle function to return to a safe level, and whether the two devices give similar readings. The goal is to find out which method is more reliable for guiding anesthesia in young children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
neuromuscular monitoring devices: electromyography (Senzime TetraGraph) and acceleromyography (Philips IntelliVue NMT Module)
What this could lead to
If one method proves more accurate, anesthesiologists could tailor drug dosing and recovery timing for young children more precisely.
What could go wrong
The trial is small and focuses on device comparison, so results may not apply to all children or all types of surgery. Device readings can vary with temperature, limb position, and other factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

107 people

The number who actually took part.

Started

Jul 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 months to 2 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients 6 months - 2 years of age * Scheduled for elective surgery under general anaesthesia with intubation and use of rocuronium * American Society of Anesthesiologists (ASA) physical status classification I to III Exclusion Criteria: * Known allergy to rocuronium * Neuromuscular disease that may interfere with neuromuscular data * Indication for rapid sequence induction * Prone position

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neuromuscular blockade are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neuromuscular blockade

Contacts and locations

Locations

  • Rigshospitalet

    Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.